Paksistan's Frontier Crimes Regulation (FCR) Saturday reserved its judgment and is expected to rule March 15 on Shakil Afridi, the doctor who helped the US track down slain Al Qaeda leader Osama bin Laden.
The defence and prosecution have completed their arguments in the case, heard by Commissioner FCR Munir Azam, reported Dawn online.
Afridi's lawyers Samiullah and Qamar Nadeem appealed against his conviction and urged the court to declare this null and void.
Afridi had helped the Central Intelligence Agency (CIA) to run a fake vaccination campaign in Abbottabad, a month before the US forces raided a compound and killed Osama bin Laden in 2011.
On May 23, 2012, he was sentenced to 33 years in prison and fined Pakistani Rs.320,000 on charges of colluding with the Lashkar-i-Islam and its chief, Mangal Bagh.
However, the court had not entertained evidence relating to Shakil Afridi's involvement with the CIA, citing lack of jurisdiction.
His sentenced was overturned in August 2013 and a retrial was ordered.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
